Skip to main content
. 2022 Nov 14;10(3):2204814. doi: 10.1002/advs.202204814

Figure 11.

Figure 11

Engineered EVs for immunotherapy. a) Schematic representation of EXO‐OVA‐mAb targeting lymph nodes and enhancing tumor‐specific T cell responses. Reproduced with permission.[ 163 ] Copyright 2020, Elsevier. ILN: inguinal lymph nodes. b) Schematic diagram of the construction of MUC1‐Dex. Reproduced with permission.[ 164 ] Copyright 2021, Elsevier.